Literature DB >> 10595922

Blood-brain barrier tight junction disruption in human immunodeficiency virus-1 encephalitis.

L M Dallasta1, L A Pisarov, J E Esplen, J V Werley, A V Moses, J A Nelson, C L Achim.   

Abstract

The blood-brain barrier (BBB) plays a critical role in regulating cell trafficking through the central nervous system (CNS) due to several unique anatomical features, including the presence of interendothelial tight junctions that form impermeable seals between the cells. Previous studies have demonstrated BBB perturbations during human immunodeficiency virus encephalitis (HIVE); however, the basis of these permeability changes and its relationship to infiltration of human immunodeficiency virus type 1 (HIV-1)-infected monocytes, a critical event in the pathogenesis of the disease, remains unclear. In this study, we examined CNS tissue from HIV-1-seronegative patients and HIV-1-infected patients, both with and without encephalitis, for alterations in BBB integrity via immunohistochemical analysis of the tight junction membrane proteins, occludin and zonula occludens-1 (ZO-1). Significant tight junction disruption (P < 0.001), as demonstrated by fragmentation or absence of immunoreactivity for occludin and ZO-1, was observed within vessels from subcortical white matter, basal ganglia, and, to a lesser extent, cortical gray matter in patients who died with HIVE. These alterations were also associated with accumulation of activated, HIV-1-infected brain macrophages, fibrinogen leakage, and marked astrocytosis. In contrast, no significant changes (P > 0.05) were observed in cerebellar tissue from patients with HIVE compared to HIV-seronegative patients or HIV-1-infected patients without encephalitis. Our findings demonstrate that tight junction disruption is a key feature of HIVE that occurs in regions of histopathological alterations in association with perivascular accumulation of activated HIV-1-infected macrophages, serum protein extravasation, and marked astrocytosis. We propose that disruption of this key BBB structure serves as the main route of HIV-1-infected monocyte entry into the CNS.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10595922      PMCID: PMC1866950          DOI: 10.1016/S0002-9440(10)65511-3

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  66 in total

Review 1.  Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Report of a Working Group of the American Academy of Neurology AIDS Task Force.

Authors: 
Journal:  Neurology       Date:  1991-06       Impact factor: 9.910

Review 2.  Reactive astrocytes: cellular and molecular cues to biological function.

Authors:  J L Ridet; S K Malhotra; A Privat; F H Gage
Journal:  Trends Neurosci       Date:  1997-12       Impact factor: 13.837

3.  Human immunodeficiency virus-infected macrophages produce soluble factors that cause histological and neurochemical alterations in cultured human brains.

Authors:  L Pulliam; B G Herndier; N M Tang; M S McGrath
Journal:  J Clin Invest       Date:  1991-02       Impact factor: 14.808

4.  CSF changes in a longitudinal study of 124 neurologically normal HIV-1-infected U.S. Air Force personnel.

Authors:  D W Marshall; R L Brey; C A Butzin; D R Lucey; S M Abbadessa; R N Boswell
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1991

5.  Evidence of serum-protein leakage across the blood-brain barrier in the acquired immunodeficiency syndrome.

Authors:  R H Rhodes
Journal:  J Neuropathol Exp Neurol       Date:  1991-03       Impact factor: 3.685

6.  Adsorptive endocytosis mediates the passage of HIV-1 across the blood-brain barrier: evidence for a post-internalization coreceptor.

Authors:  W A Banks; V Akerstrom; A J Kastin
Journal:  J Cell Sci       Date:  1998-02       Impact factor: 5.285

7.  The tight-junction-specific protein ZO-1 is a component of the human and rat blood-brain barriers.

Authors:  P M Watson; J M Anderson; C M Vanltallie; S R Doctrow
Journal:  Neurosci Lett       Date:  1991-08-05       Impact factor: 3.046

8.  Neocortical damage during HIV infection.

Authors:  C A Wiley; E Masliah; M Morey; C Lemere; R DeTeresa; M Grafe; L Hansen; R Terry
Journal:  Ann Neurol       Date:  1991-06       Impact factor: 10.422

9.  Single-photon emission computed tomography in human immunodeficiency virus encephalopathy: a preliminary report.

Authors:  J C Masdeu; A Yudd; R L Van Heertum; M Grundman; E Hriso; R A O'Connell; D Luck; U Camli; L N King
Journal:  J Nucl Med       Date:  1991-08       Impact factor: 10.057

10.  Human immunodeficiency virus type 1-infected monocytic cells can destroy human neural cells after cell-to-cell adhesion.

Authors:  M Tardieu; C Héry; S Peudenier; O Boespflug; L Montagnier
Journal:  Ann Neurol       Date:  1992-07       Impact factor: 10.422

View more
  138 in total

Review 1.  Epidemiological evidence and molecular basis of interactions between HIV and JC virus.

Authors:  J R Berger; A Chauhan; D Galey; A Nath
Journal:  J Neurovirol       Date:  2001-08       Impact factor: 2.643

2.  Molecular and functional characterization of riboflavin specific transport system in rat brain capillary endothelial cells.

Authors:  Mitesh Patel; Ramya Krishna Vadlapatla; Dhananjay Pal; Ashim K Mitra
Journal:  Brain Res       Date:  2012-06-07       Impact factor: 3.252

3.  Methamphetamine and HIV-1 gp120 effects on lipopolysaccharide stimulated matrix metalloproteinase-9 production by human monocyte-derived macrophages.

Authors:  Jessica L Reynolds; Supriya D Mahajan; Ravikumar Aalinkeel; Bindukumar Nair; Donald E Sykes; Stanley A Schwartz
Journal:  Immunol Invest       Date:  2011-03-22       Impact factor: 3.657

4.  HIV-induced chorea: evidence for basal ganglia dysregulation by SPECT.

Authors:  B Sporer; R Linke; K Seelos; R Paul; T Klopstock; H-W Pfister
Journal:  J Neurol       Date:  2005-02-23       Impact factor: 4.849

5.  Correlation between breakdown of the blood-brain barrier and disease outcome of viral encephalitis in mice.

Authors:  Aaron L Olsen; John D Morrey; Donald F Smee; Robert W Sidwell
Journal:  Antiviral Res       Date:  2006-12-20       Impact factor: 5.970

6.  Enhancement of blood-brain barrier permeability and reduction of tight junction protein expression are modulated by chemokines/cytokines induced by rabies virus infection.

Authors:  Qingqing Chai; Wen Q He; Ming Zhou; Huijun Lu; Zhen F Fu
Journal:  J Virol       Date:  2014-02-12       Impact factor: 5.103

7.  PPARalpha and PPARgamma attenuate HIV-induced dysregulation of tight junction proteins by modulations of matrix metalloproteinase and proteasome activities.

Authors:  Wen Huang; Sung Yong Eum; Ibolya E András; Bernhard Hennig; Michal Toborek
Journal:  FASEB J       Date:  2009-01-13       Impact factor: 5.191

8.  Caveolin-1 regulates human immunodeficiency virus-1 Tat-induced alterations of tight junction protein expression via modulation of the Ras signaling.

Authors:  Yu Zhong; Eric J Smart; Babette Weksler; Pierre-Olivier Couraud; Bernhard Hennig; Michal Toborek
Journal:  J Neurosci       Date:  2008-07-30       Impact factor: 6.167

9.  Endothelial cell suppression of peripheral blood mononuclear cell trafficking in vitro during acute exposure to feline immunodeficiency virus.

Authors:  Lola C Hudson; Mary B Tompkins; Rick B Meeker
Journal:  Cell Tissue Res       Date:  2008-07-30       Impact factor: 5.249

10.  Human immunodeficiency virus type 1 gp120-mediated disruption of tight junction proteins by induction of proteasome-mediated degradation of zonula occludens-1 and -2 in human brain microvascular endothelial cells.

Authors:  Shinichi Nakamuta; Hiroshi Endo; Youichiro Higashi; Aoi Kousaka; Hiroshi Yamada; Mihiro Yano; Hiroshi Kido
Journal:  J Neurovirol       Date:  2008-05       Impact factor: 2.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.